MSDC to Present Recent Findings on the Therapeutic Potential of Increasing Brown Fat in the Treatment of Diabetes at Annual American Diabetes Association Conference

Kalamazoo, Mich. (June 21, 2011) – Metabolic Solutions Development Company (MSDC) and collaborators will present their research providing insights into the therapeutic potential of increasing brown adipose tissue in the treatment of diabetes and the unique mechanism of action of the company’s novel insulin sensitizers that connects with pathways known to be dysregulated in diabetes at the American Diabetes Association’s (ADA) 71st annual Scientific Sessions conference in San Diego, Calif., June 24-28, 2011. The ADA conference is the world’s leading scientific and medical meeting focused on diabetes. All sessions at the ADA will be held in the San Diego Convention Center.

PDF:
MSDC to Present Findings at ADA Conference 2011_6-21-2011